Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Bradley Corr

Concepts (165)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Endometrial Neoplasms
9
2023
141
3.210
Why?
Ovarian Neoplasms
7
2022
386
1.980
Why?
Carcinoma, Endometrioid
3
2022
46
1.960
Why?
beta Catenin
4
2023
220
1.460
Why?
Lymph Nodes
2
2018
422
0.960
Why?
Wnt Signaling Pathway
2
2021
147
0.840
Why?
Uterine Cervical Neoplasms
5
2023
212
0.740
Why?
Wnt Proteins
1
2021
134
0.700
Why?
Mutation
5
2023
3350
0.670
Why?
Adenocarcinoma, Mucinous
1
2018
61
0.570
Why?
Gynecologic Surgical Procedures
2
2020
43
0.550
Why?
Venous Thromboembolism
2
2020
231
0.530
Why?
Cisplatin
2
2023
262
0.510
Why?
Neoplasms, Glandular and Epithelial
1
2015
34
0.510
Why?
Keratin-5
1
2015
46
0.500
Why?
Tumor Suppressor Protein p53
4
2023
447
0.490
Why?
Neoplasm Recurrence, Local
2
2023
856
0.490
Why?
Hysterectomy
4
2019
106
0.480
Why?
Antineoplastic Agents
4
2023
1879
0.450
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2023
1353
0.450
Why?
Bile Ducts, Intrahepatic
1
2013
49
0.440
Why?
Cholangiocarcinoma
1
2013
38
0.440
Why?
Bile Duct Neoplasms
1
2013
56
0.430
Why?
Genital Neoplasms, Female
3
2024
70
0.400
Why?
Lymph Node Excision
3
2018
140
0.390
Why?
Neoplasm Grading
3
2022
243
0.370
Why?
Biomarkers, Tumor
4
2023
1045
0.350
Why?
Female
27
2024
59613
0.340
Why?
Middle Aged
17
2023
26827
0.280
Why?
Aged, 80 and over
11
2023
6357
0.270
Why?
Immunohistochemistry
2
2023
1634
0.260
Why?
Cell Survival
2
2021
1022
0.250
Why?
Humans
29
2024
115042
0.240
Why?
Cell Line, Tumor
3
2021
2715
0.230
Why?
Bevacizumab
2
2022
115
0.220
Why?
Neoplasms
3
2022
2106
0.220
Why?
Poly-ADP-Ribose Binding Proteins
2
2023
31
0.220
Why?
DNA Polymerase II
2
2023
37
0.220
Why?
Tertiary Care Centers
1
2023
126
0.210
Why?
Fallopian Tube Neoplasms
1
2022
13
0.200
Why?
Aged
13
2023
19119
0.200
Why?
Camptothecin
1
2022
96
0.200
Why?
Thrombocytopenia
1
2023
178
0.190
Why?
Heterocyclic Compounds, 3-Ring
1
2021
29
0.190
Why?
Retrospective Studies
6
2022
12547
0.190
Why?
Indazoles
1
2021
58
0.190
Why?
Neoplasm Staging
3
2019
1169
0.180
Why?
High-Throughput Nucleotide Sequencing
1
2023
441
0.180
Why?
Clinical Trials, Phase I as Topic
1
2020
45
0.180
Why?
Benzoxazoles
1
2020
16
0.180
Why?
Imidazoles
1
2021
209
0.170
Why?
Mindfulness
1
2021
97
0.170
Why?
Azepines
1
2020
74
0.170
Why?
Enoxaparin
1
2020
52
0.170
Why?
Disease Susceptibility
1
2021
316
0.160
Why?
Pyridones
1
2020
125
0.160
Why?
Microsatellite Instability
1
2019
32
0.160
Why?
Survival Analysis
3
2020
1211
0.160
Why?
Margins of Excision
1
2019
29
0.160
Why?
Drug Resistance, Neoplasm
3
2020
636
0.160
Why?
Gene Expression Regulation, Neoplastic
2
2021
1144
0.160
Why?
Class I Phosphatidylinositol 3-Kinases
1
2019
76
0.160
Why?
Cross-Sectional Studies
3
2018
4411
0.160
Why?
Adult
12
2023
30656
0.160
Why?
Molecular Targeted Therapy
1
2021
347
0.160
Why?
Protein Kinase Inhibitors
2
2023
786
0.150
Why?
Recurrence
1
2021
941
0.150
Why?
Oncologists
1
2018
30
0.150
Why?
PTEN Phosphohydrolase
1
2019
140
0.150
Why?
Frozen Sections
1
2018
24
0.150
Why?
Pyridines
1
2021
425
0.150
Why?
Preoperative Care
2
2017
318
0.150
Why?
Disease Management
1
2021
563
0.140
Why?
Pyrimidines
1
2020
375
0.140
Why?
Pyrazoles
1
2020
362
0.140
Why?
Minority Groups
1
2018
228
0.140
Why?
Amyotrophic Lateral Sclerosis
3
2003
61
0.140
Why?
Antibodies, Monoclonal, Humanized
1
2020
665
0.130
Why?
Anticoagulants
1
2020
546
0.130
Why?
Gynecology
1
2018
163
0.130
Why?
Tissue Array Analysis
1
2015
49
0.130
Why?
Neoplasm Invasiveness
1
2017
442
0.130
Why?
Perioperative Period
1
2015
49
0.130
Why?
Radiography, Thoracic
1
2016
163
0.120
Why?
Surgeons
1
2018
236
0.120
Why?
Laparotomy
1
2015
97
0.120
Why?
Treatment Outcome
3
2020
9122
0.120
Why?
Heparin
1
2015
222
0.110
Why?
Quality of Health Care
1
2018
573
0.110
Why?
Robotic Surgical Procedures
1
2015
86
0.110
Why?
Membrane Proteins
1
2019
1019
0.110
Why?
Receptors, Estrogen
1
2015
372
0.110
Why?
Postoperative Complications
2
2020
2150
0.100
Why?
Breast Neoplasms
1
2024
1865
0.100
Why?
Combined Modality Therapy
2
2013
1127
0.100
Why?
Prognosis
5
2023
3334
0.100
Why?
Ovary
1
2013
191
0.100
Why?
Case-Control Studies
1
2019
3015
0.100
Why?
Prospective Studies
4
2023
6232
0.090
Why?
Maximum Tolerated Dose
2
2022
183
0.090
Why?
Cohort Studies
2
2023
4904
0.090
Why?
Immunotherapy
1
2012
474
0.080
Why?
Cell Proliferation
1
2015
2191
0.080
Why?
Apoptosis
1
2015
2366
0.070
Why?
Young Adult
4
2021
10498
0.060
Why?
Carbonyl Reductase (NADPH)
1
2024
4
0.060
Why?
Wnt4 Protein
1
2024
17
0.060
Why?
DNA Mismatch Repair
1
2023
37
0.060
Why?
Registries
3
2018
1763
0.050
Why?
Lung Neoplasms
1
2016
2201
0.050
Why?
Mesylates
1
2022
8
0.050
Why?
Topoisomerase I Inhibitors
1
2022
15
0.050
Why?
AMP-Activated Protein Kinases
1
2024
175
0.050
Why?
Platinum
1
2022
38
0.050
Why?
Ligands
1
2024
565
0.050
Why?
Antibodies, Bispecific
1
2022
32
0.050
Why?
Adolescent
4
2021
17864
0.050
Why?
Ambulatory Care Facilities
1
2003
211
0.050
Why?
Paclitaxel
1
2022
190
0.050
Why?
Decision Trees
1
2000
81
0.040
Why?
Aurora Kinase A
1
2020
51
0.040
Why?
Mechanistic Target of Rapamycin Complex 2
1
2020
55
0.040
Why?
Mechanistic Target of Rapamycin Complex 1
1
2020
95
0.040
Why?
Vascular Endothelial Growth Factor A
1
2022
499
0.040
Why?
Tumor Microenvironment
1
2022
431
0.040
Why?
Patient Care Team
1
2003
515
0.040
Why?
Neoplasm Metastasis
1
2020
524
0.040
Why?
Xenograft Model Antitumor Assays
1
2020
697
0.040
Why?
Ireland
3
2003
24
0.040
Why?
Program Evaluation
1
2021
825
0.040
Why?
Chemoradiotherapy
1
2018
187
0.040
Why?
Disease Progression
2
2020
2389
0.030
Why?
Neoadjuvant Therapy
1
2018
298
0.030
Why?
Regression Analysis
1
2019
948
0.030
Why?
RNA
1
2022
810
0.030
Why?
Ileus
1
2015
10
0.030
Why?
Salpingectomy
1
2015
12
0.030
Why?
Caregivers
1
2021
712
0.030
Why?
Urinary Retention
1
2015
19
0.030
Why?
Survival Rate
1
2019
1646
0.030
Why?
Ovariectomy
1
2015
117
0.030
Why?
Blood Loss, Surgical
1
2015
86
0.030
Why?
Pelvis
1
2015
90
0.030
Why?
Referral and Consultation
1
2018
633
0.030
Why?
Logistic Models
1
2018
1839
0.030
Why?
Pandemics
1
2021
1321
0.030
Why?
Follow-Up Studies
2
2018
4420
0.030
Why?
Patient Readmission
1
2018
606
0.030
Why?
United States
2
2019
12226
0.030
Why?
Signal Transduction
1
2024
4525
0.020
Why?
Immunotherapy, Adoptive
1
2012
184
0.020
Why?
Length of Stay
1
2015
950
0.020
Why?
Practice Patterns, Physicians'
1
2018
1177
0.020
Why?
Quality of Life
1
2020
2359
0.020
Why?
Patient Discharge
1
2015
767
0.020
Why?
Age Factors
1
2015
2894
0.020
Why?
Diagnosis, Differential
2
2003
1355
0.020
Why?
Antibodies, Monoclonal
1
2012
1268
0.020
Why?
Mice
1
2020
14927
0.010
Why?
Male
4
2020
55731
0.010
Why?
Interprofessional Relations
1
2003
251
0.010
Why?
Central Nervous System Diseases
1
2000
61
0.010
Why?
Animals
1
2020
31867
0.010
Why?
Age of Onset
1
2000
449
0.010
Why?
Palliative Care
1
2003
639
0.010
Why?
Corr's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)